Appendix table. Number of defendants in U.S. district courte convicted, dismissed, or sentenced to prison, by offense, 1980-87

Interest in criminal justice (or organization and title if you put home address above):

Office of the Attorney General
Washington, D. C. 20530

June 20, 1990

The Honorable Joseph R. Biden, Jr.

Chairman

Committee on the Judiciary

United States Senate

Washington, D.C. 20510

Dear Mr. Chairman,

Enclosed are responses to the follow-up questions you sent on behalf of the Committee. We still await others which will be forthcoming from Senator Leahy.

I hope you will find the attached useful. In any event, please do not hesitate to contact me if I can provide further information on any matter.

CC:

Strom Thurmond

Ranking Minority Member

ince ex

Dick Thornburgh

Q:

QUESTIONS FROM SENATOR BIDEN

Transferring money to federal agencies. In response to my follow up questions from the first authorization hearing, you stated that more than $19 million will be transferred from the Bureau of Justice Assistance discretionary grant program to other federal agencies and other agencies in the Office of Justice Programs. Many of these agencies, however, already receive appropriated funds for programs and purposes similar to the programs that will be funded out of the BJS discretionary grant

funds.

For each of the grants that will be transferred to non-BJA agencies (including Office of Justice Programs agencies) please explain why these programs will be funded out of the discretionary drug grants and not from these agencies' general budgets.

A:

As

The earlier response described a number of programs involving collaborative efforts with other Federal agencies. noted in that response, the precise extent of collaboration, including whether a transfer of funds would be necessary, has not yet been determined in many cases. These collaborative efforts may involve projects in which the Bureau of Justice Assistance (BJA) and other agencies have "overlapping" authorized purpose areas. Therefore, the statutory missions of participating agencies may be advanced by the BJA grant. BJA has determined in each case that such projects fall within its authorization and are of sufficient priority (in many cases, as determined by reference to the President's "National Drug Control Strategy") to justify funding at the level indicated.

Following is a list of projects that involve, or are likely to involve, substantial collaborative efforts. This replaces the earlier submission and reflects additional review of the program plan and additional progress achieved in implementation of the program plan. Items marked with an asterisk have entailed, or are expected under the terms of the program plan to entail, a transfer of funds from BJA. In response to your question, a rationale for the transfer is also provided. In other cases, transfer will not be necessary or is yet to be determined. list is subject to change as final decisions on program implementation are made. (A copy of the BJA "FY 1990 Discretionary Program Announcement" is attached for further reference. It contains additional details for each of the projects contained in the list included herein.)

a

This

41-083 91 - 8

Rationale: DEA devotes substantial resources to the Federal enforcement portion of this multi-jurisdictional effort. DEA expertise will improve the safe and efficient management of this sensitive project.

Rationale: OJJDP will devote about $750,000 and NIJ about $200,000 to this project as well.

OJJDP expertise will enhance the

Rationale: Continuation of joint BJA/NIJ evaluation program begun in FY 1989. NIJ devotes about $1 million to this program, pursuant to 42 U.S.C. sec. 3766. NIJ expertise in this area will benefit the quality of the product.